Gabapentin Capsule
Product Images NDC 63629-8488

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-8488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph comparing mean pain scores over an 8-week period for placebo versus Gabapentin 3600 mg/day. The x-axis shows weeks from baseline to week 8, and the y-axis shows mean pain scores from 0 to 10. The graph indicates a 4-week dose titration period followed by a 4-week fixed dose period, with Gabapentin showing a decreasing pain score trend compared to relatively stable pain scores for placebo.*

FDA Label Image

Figure 2 (Image 02)

Line graph showing mean pain scores over 7 weeks comparing placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The timeline includes a 3-week dose titration period followed by a 4-week fixed dose period. Pain scores generally decrease more with gabapentin dosages than with placebo over time.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) dosages in two studies. Study 1 shows 12% responders for placebo and 29% for GBP 3600 mg. Study 2 shows 14% responders for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance levels are noted with p-values < 0.01 and < 0.001.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

A mathematical formula showing the calculation for creatinine clearance (CLCr), involving variables for age, weight, serum creatinine level, and a factor for female patients. The formula is presented in a fraction format with multipliers and a parenthetical adjustment for gender.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin showing a cyclohexane ring bonded to aminomethyl and acetic acid groups.*

FDA Label Image

Image-09 (Image 09)

A scatter plot showing the percentage difference on the y-axis versus daily dose in mg on the x-axis, with data points labeled a, b, and c representing three studies (STUDY a, STUDY b, STUDY c) at daily doses of 600, 900, 1200, and 1800 mg.*

FDA Label Image

Label (Lbl636298488)

Label for Gabapentin Capsules, USP, 400 mg, an oral prescription drug by Bryant Ranch Prepack. The label indicates 100 capsules per container and includes storage instructions, manufacturer details (Sciegen Pharmaceuticals, Inc., Hauppauge, NY), child-resistant closure warning, and barcodes. The label shows NDC 63629-8488-1 and the BRP Pharmaceuticals logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.